Century Therapeutics, Inc. (IPSC)
Data as of , from SEC Form 4 filings.
See up to 3 months of IPSC. The 7-day demo opens the 1M and 3M ranges and puts IPSC on your watchlist.
Start 7-day demoLatest IPSC insider trades
About Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. is an SEC registrant, filing under CIK 0001850119, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
IPSC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 5,308 | $10K |
| Grant or award | 1 | 148,000 | |
| Tax withholding / forfeiture | 3 | 45,485 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IPSC insider transactions (Form 4)
3356 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Douglas Carr - Officer | Open-market sale | Common Stock | 247 | $2.54 | $626 | |
| Brent Pfeiffenberger - Officer | Tax withholding / forfeiture | Common Stock | 463 | $2.56 | $1K | |
| Brent Pfeiffenberger - Officer | Tax withholding / forfeiture | Common Stock | 31,172 | $1.75 | $55K | |
| Douglas Carr - Officer | Open-market sale | Common Stock | 323 | $1.82 | $589 | |
| Brent Pfeiffenberger - Officer | Grant or award | Common Stock | 475,000 | $0.00 | - | |
| Brent Pfeiffenberger - Officer | Grant or award | Stock Option (right to buy) | 945,000 | $0.00 | - | |
| Gregory Russotti - Officer | Grant or award | Stock Option (right to buy) | 265,000 | $0.00 | - | |
| Gregory Russotti - Officer | Grant or award | Common Stock | 135,000 | $0.00 | - | |
| Chad Cowan - Officer | Grant or award | Common Stock | 135,000 | $0.00 | - | |
| Chad Cowan - Officer | Grant or award | Stock Option (right to buy) | 265,000 | $0.00 | - | |
| Douglas Carr - Officer | Grant or award | Common Stock | 110,000 | $0.00 | - | |
| Douglas Carr - Officer | Grant or award | Stock Option (right to buy) | 225,000 | $0.00 | - | |
| Brent Pfeiffenberger - Officer | Open-market purchase | Common Stock | 52,000 | $0.58 footnote F2 | $30K | |
| ||||||
| Chad Cowan - Officer | Open-market sale | Common Stock | 5,462 | $0.50 | $3K | |
| Brent Pfeiffenberger - Officer | Open-market purchase | Common Stock | 35,000 | $0.50 footnote F2 | $17K | |
| ||||||
| Brent Pfeiffenberger - Officer | Open-market sale | Common Stock | 32,456 | $0.45 | $15K | |
| Douglas Carr - Officer | Open-market sale | Common Stock | 292 | $0.59 | $171 | |
| Chad Cowan - Officer | Grant or award | Common Stock | 762,543 | $0.00 | - | |
| Douglas Carr - Officer | Open-market sale | Common Stock | 263 | $0.50 | $132 | |
| Brent Pfeiffenberger - Officer | Open-market sale | Common Stock | 488 | $0.50 | $244 | |
| Gregory Russotti - Officer | Open-market sale | Common Stock | 539 | $0.50 | $270 | |
| Brent Pfeiffenberger - Officer | Grant or award | Common Stock | 1,587,614 | $0.00 | - | |
| Douglas Carr - Officer | Open-market sale | Common Stock | 296 | $0.53 | $158 | |
| Cynthia M. Butitta - Director | Grant or award | Stock Option (right to buy) | 44,000 | $0.00 | - | |
 Joseph Jimenez - Director | Grant or award | Stock Option (right to buy) | 44,000 | $0.00 | - | |
| Brent Pfeiffenberger - Officer | Tax withholding / forfeiture | Common Stock | 243,447 | $1.44 | $351K | |
| Adrienne Farid - Officer | Open-market sale | Common Stock | 1,033 | $1.23 | $1K | |
| Douglas Carr - Officer | Tax withholding / forfeiture | Common Stock | 16,611 | $1.26 | $21K | |
| Douglas Carr - Officer | Open-market sale | Common Stock | 283 | $1.23 | $347 | |
| Morgan Conn - Officer | Grant or award | Common Stock | 60,148 | $0.00 | - | |
| Morgan Conn - Officer | Grant or award | Stock Option (right to buy) | 360,890 | $0.00 | - | |
| Chad Cowan - Officer | Grant or award | Common Stock | 74,376 | $0.00 | - | |
| Chad Cowan - Officer | Grant or award | Stock Option (right to buy) | 446,250 | $0.00 | - | |
Recent IPSC Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Carr Douglas | Officer | 1,658 | $3K | View on EDGAR | |
| Russotti Gregory | Officer | 2,587 | $5K |
IPSC insider trading FAQ
What is the latest insider trade for IPSC?
Century Therapeutics, Inc. (IPSC) had 9 insider filings in the last 90 days, with the most recent on 2026-09-15. The full record for IPSC runs to 56 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IPSC stock?
No insider purchases of IPSC were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling IPSC stock?
5 insider sales of IPSC were filed in the last 90 days, totaling $10K.
Where can I see IPSC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IPSC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gregory Russotti view on EDGAR
- - Douglas Carr view on EDGAR
- - Brent Pfeiffenberger view on EDGAR
- - Joseph Truitt view on EDGAR
- - Brent Pfeiffenberger view on EDGAR
- - Gregory Russotti view on EDGAR
- - Douglas Carr view on EDGAR
- - Brent Pfeiffenberger view on EDGAR
- - Douglas Carr view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IPSC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IPSC with a 7-day demo
- IPSC on your watchlist
- Every IPSC Form 4 filing on record
- Up to 3 months of IPSC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
